Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-31

Study Completion Date

2029-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this project is to collect information from the doctor notes about the use of the device, to monitor the tubes after surgery, and collect information from patients and parents/guardians about their views on the procedure. Since the device became available in Europe, it is important to collect information from both patients planned for the procedure (prospective) and those who already underwent the procedure (retrospective) to have collect as much data as possible.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Study of Solo Tympanostomy Tube Device (TTD)

NCT02957578

Otitis Media Middle Ear Effusion

UNKNOWN NA

Middle Ear Disease Before Age 3, Treatment With Ear Tubes, and Literacy and Attentional Abilities at Ages 9 to 11

NCT00365092

Otitis Media Middle Ear Effusion

COMPLETED NA

Eustachian Tube Growth and Development

NCT00422929

Otitis Media

COMPLETED

Middle Ear Pressure Disregulation After Tympanostomy Tube Insertion

NCT00393900

Otitis Media With Effusion

COMPLETED

Eustachian Tube Testing in a Pressure Chamber -- Validation Study

NCT00694486

Otitis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are being asked to participate in this study because they have been treated, will be treated, or have undergone a treatment attempt with the Solo+ Tympanostomy Tube Device (Solo+ TTD), manufactured by AventaMed. The Solo+ TTD device is a CE marked device designed to deploy ear tubes across the ear drum.

Ear tubes (also known as tympanostomy tubes or ventilation tubes) are predominantly used in treating repeated or long-term middle ear infections, or to treat a build-up of fluid in the middle ear, mostly in children, yet also used for adults. Ear tube insertion allows for air to ventilate the middle ear space and drain fluid from the middle ear.

The Solo+ Tympanostomy Tube Device (Solo+ TTD) is an all-in-one device for the insertion of ear tubes using as little as topical anaesthesia, without requiring general anaesthesia as is the case for other similar devices. The Solo+ TTD is approved for use in children and adults. It is available in Europe and already in use by some clinics and hospitals.

The purpose of this study is to collect information about the use the Solo+ TTD.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Otitis Media Middle Ear Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

adults and pedriatic patients who have had eartubes inserted, both prospective and retrospective.

Solo+ Tympanostomy Tube Device (Solo+ TTD)

Intervention Type DEVICE

insertion of eartubes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Solo+ Tympanostomy Tube Device (Solo+ TTD)

insertion of eartubes

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject and/or Parent/Guardian is able to understand the information document and (depending in the country's legislation) does not object participating or is willing to provide documented informed consent
* Subject was or will be treated, or had a treatment attempted with the study device.